{"id":391290,"title":"Frequently Asked Questions - GlaxoSmithKline, ID Biomedical, Sainte-Foy Facility - Posting of Health Canada June 2014 Inspection Summary Report - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-14","captureTimestamp":"2026-04-14T04:24:48.885000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/frequently-asked-questions-glaxosmithkline-biomedical-sainte-facility-summary-report.html","snippet":"Frequently Asked Questions - GlaxoSmithKline, ID Biomedical, Sainte-Foy Facility - Posting of Health Canada June 2014 Inspection Summary Report Q.1 What did Health Canada find during its June 2014 inspection of the ID Biomedical, Ste-Foy facility? Health Canada carried out a…","rawSnapshotUrl":"/api/snapshots/raw/391290","browseUrl":"https://replay.healtharchive.ca/job-6/20260414042448/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/frequently-asked-questions-glaxosmithkline-biomedical-sainte-facility-summary-report.html#ha_snapshot=391290","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}